Mario Gabelli's REGN Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 646 shares of Regeneron Pharmaceuticals, Inc. (REGN) worth $363,226, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in REGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 198 shares. Largest reduction occurred in Q3 2016, reducing 800 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Regeneron Pharmaceuticals (REGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Regeneron Pharmaceuticals (REGN) Trades by Mario Gabelli
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +2,295 | New Buy | 2,295 | $282.35 |
| Q3 2014 | -105 | Reduce 4.58% | 2,190 | $360.73 |
| Q2 2015 | -45 | Reduce 2.05% | 2,145 | $510.02 |
| Q4 2015 | -767 | Reduce 35.76% | 1,378 | $542.82 |
| Q1 2016 | -35 | Reduce 2.54% | 1,343 | $360.39 |
| Q2 2016 | -14 | Reduce 1.04% | 1,329 | $349.13 |
| Q3 2016 | -800 | Reduce 60.20% | 529 | $402.65 |
| Q4 2016 | -529 | Sold Out | 529 | $0.00 |
| Q2 2017 | +492 | New Buy | 492 | $491.87 |
| Q3 2017 | -10 | Reduce 2.03% | 482 | $448.13 |
| Q4 2017 | -482 | Sold Out | 482 | $0.00 |
| Q1 2024 | +239 | New Buy | 239 | $962.49 |
| Q2 2024 | +68 | Add 28.45% | 307 | $1051.03 |
| Q3 2024 | +58 | Add 18.89% | 365 | $1051.24 |
| Q4 2024 | +198 | Add 54.25% | 563 | $712.33 |
| Q1 2025 | +26 | Add 4.62% | 589 | $634.23 |
| Q2 2025 | +13 | Add 2.21% | 602 | $525.00 |
| Q3 2025 | +44 | Add 7.31% | 646 | $562.27 |
Mario Gabelli's Regeneron Pharmaceuticals Investment FAQs
Mario Gabelli first purchased Regeneron Pharmaceuticals, Inc. (REGN) in Q2 2014, acquiring 2,295 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Regeneron Pharmaceuticals, Inc. (REGN) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's largest addition to Regeneron Pharmaceuticals, Inc. (REGN) was in Q2 2014, adding 2,295 shares worth $648,000. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 646 shares of Regeneron Pharmaceuticals, Inc. (REGN), valued at approximately $363,226. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Regeneron Pharmaceuticals, Inc. (REGN) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's peak holding in Regeneron Pharmaceuticals, Inc. (REGN) was 2,295 shares, as reported at the end of Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.